Sci-Tech News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.

Press releases published on September 2, 2026

Sep. 2, 2026

Inventiva annonce la dernière visite du dernier patient de l’étude clinique de Phase 3 NATiV3 évaluant le lanifibranor dans la MASH

Indeterminate GlobeNewswire

Sep. 2, 2026

Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 2, 2026

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

nCino to Participate in Upcoming Investor Event 

Indeterminate GlobeNewswire

Sep. 2, 2026

Surrozen to Present at Upcoming Healthcare Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

Kyverna Therapeutics to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

Shattuck Labs Announces Participation in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

Netskope Announces Strong Second Quarter Fiscal 2027 Financial Results

Indeterminate GlobeNewswire

Sep. 2, 2026

Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

SPS Commerce to Present at Citi's 2026 Global TMT Conference

Indeterminate GlobeNewswire

Sep. 2, 2026

Scribe Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

Indeterminate GlobeNewswire

Sep. 2, 2026

Matrix Service Company Reports Fiscal Year 2026 Fourth Quarter and Full-Year Results

Indeterminate GlobeNewswire

Sep. 2, 2026

Zhejiang University School of Medicine Study Uncovers the Role of Endometrial Defects in Abnormal Uterine Bleeding

Indeterminate EIN Presswire

Sep. 2, 2026

AI Is Redefining Cognitive Care: Global Survey Reveals What Professionals Want Next

Indeterminate EIN Presswire

Sep. 2, 2026

Aura Biosciences to Participate in Upcoming Investor Conference

Indeterminate GlobeNewswire

Sep. 2, 2026

Kymera Therapeutics to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

Sep. 2, 2026

Black Diamond Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 2, 2026

Spero Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 2, 2026

Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 2, 2026

Ultragenyx Announces Phase 3 Aspire results in Angelman Syndrome

Indeterminate GlobeNewswire